Skip to content

A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510467-35-00
Acronym
67953964MDD1011
Enrollment
18
Registered
2024-05-06
Start date
2024-06-05
Completion date
2024-07-29
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Participants.

Interventions

None listed

Sponsors

Janssen Cilag International
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026